Form 4: Enhabit EVP Reports RSU Vesting and Tax-Related Stock Sales

Enhabit's EVP of Hospice Operations, Jeanne Louise Kalvaitis, reported the acquisition of shares from RSU vesting and subsequent sales to cover tax obligations.

Summary

• Jeanne Louise Kalvaitis, Executive Vice President of Hospice Operations at Enhabit, Inc. (EHAB), reported transactions involving the company's common stock.
• On February 27, 2026, Kalvaitis acquired 9,824 shares of common stock at a price of $13.58 per share. This acquisition resulted from the vesting of performance-based restricted stock units (RSUs) tied to a three-year performance period from 2023 to 2025.
• To cover tax withholding obligations incurred from the RSU vesting, Kalvaitis disposed of a total of 4,055 shares of common stock across three separate transactions: 2,915 shares on February 27, 2026, at $13.58 per share, and 578 shares and 562 shares on March 1, 2026, both at $13.61 per share.
• Following these reported transactions, Kalvaitis's direct beneficial ownership of Enhabit common stock stands at 51,748 shares.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, as the vesting of performance-based RSUs suggests the company met its targets for the 2023-2025 period, reflecting positively on past performance and management's alignment.

Positives

• The acquisition of 9,824 shares through RSU vesting indicates the successful achievement of performance targets for the 2023-2025 period, reflecting positively on past company performance.
• The vesting of performance-based restricted stock units aligns management incentives with long-term company performance and shareholder value creation.

Negatives

• The disposal of 4,055 shares to cover tax obligations reduces the insider's direct ownership, although this is a common and non-discretionary practice for equity compensation.

Risks

• No specific risks are mentioned in this Form 4 filing; the reported transactions are routine for equity compensation.

Future Outlook

The filing itself does not contain forward-looking statements or guidance beyond the historical performance period for the vested RSUs (2023-2025).

Management Comments

• "These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock."
• "Shares received from the vesting of performance-based restricted stock units, which had a three-year performance period from 2023 to 2025."

Industry Context

StockSavvy.ai notes that the vesting of performance-based restricted stock units is a standard practice in executive compensation across the healthcare industry, particularly for publicly traded companies like Enhabit. This mechanism aims to align executive incentives with shareholder value creation over multi-year performance cycles. The subsequent sale of shares to cover tax obligations is also a routine and expected event in such compensation structures.

Comparison to Industry Standards

• The use of performance-based restricted stock units (RSUs) with a three-year performance period (2023-2025) is consistent with common executive compensation practices seen in healthcare companies such as Amedisys (AMED) or LHC Group (LHCG) before its acquisition, which often tie a significant portion of executive pay to long-term operational and financial metrics.
• The practice of 'sell-to-cover' for tax withholding upon RSU vesting is a standard, non-discretionary transaction, widely observed across all industries, including healthcare, and does not typically signal a change in management's confidence in the company's future.

Stakeholder Impact

• Shareholders: The vesting of performance-based RSUs suggests that the company achieved its performance targets for the 2023-2025 period, which could be viewed positively as it indicates management's alignment with shareholder interests.
• Employees: No direct impact on employees is mentioned, but successful RSU vesting can be a morale booster for other employees with similar compensation structures.

Next Steps

• No specific future actions or milestones are mentioned in this Form 4 filing.

Key Dates

Recommendation

The filing details routine insider transactions related to executive compensation (RSU vesting and tax withholding). While the vesting indicates past performance targets were met, these transactions do not provide new fundamental information to warrant a change in investment recommendation. The 'hold' recommendation reflects the neutral impact of these expected, non-discretionary events on the company's overall investment thesis.

Keywords

Enhabit, EHAB, Form 4, Insider Transaction, Stock Vesting, Restricted Stock Units, Executive Compensation, Jeanne Louise Kalvaitis, Hospice Operations